Acceleron Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083
October 14, 2014 at 07:30 AM EDT
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and ...